Literature DB >> 8200694

Should we ban B6 supplementation of INH therapy in childhood tuberculosis?

G P Mathur1, S Mathur, S Rastogi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8200694     DOI: 10.1007/bf02751037

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  7 in total

Review 1.  Isoniazid--the pivot of chemotherapy in tuberculosis.

Authors:  V Seth
Journal:  Indian Pediatr       Date:  1990-02       Impact factor: 1.411

Review 2.  Antituberculosis regimens of chemotherapy. Recommendations from the Committee on Treatment of the International Union against Tuberculosis and Lung Disease.

Authors: 
Journal:  Bull Int Union Tuberc Lung Dis       Date:  1988-06

3.  Vitamin A deficiency.

Authors:  G P Mathur; K P Kushwaha
Journal:  Indian Pediatr       Date:  1987-07       Impact factor: 1.411

Review 4.  Tuberculosis in children.

Authors:  D E Snider; H L Rieder; D Combs; A B Bloch; C H Hayden; M H Smith
Journal:  Pediatr Infect Dis J       Date:  1988-04       Impact factor: 2.129

5.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1990-05       Impact factor: 9.139

Review 6.  Modern approach to the diagnosis and treatment of tuberculosis in children.

Authors:  J R Starke
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

Review 7.  Clinical pharmacology of antitubercular drugs.

Authors:  M D Reed; J L Blumer
Journal:  Pediatr Clin North Am       Date:  1983-02       Impact factor: 3.278

  7 in total
  1 in total

Review 1.  Recommendations Concerning the First-Line Treatment of Children with Tuberculosis.

Authors:  Nicola Principi; Luisa Galli; Laura Lancella; Marina Tadolini; Giovanni Battista Migliori; Alberto Villani; Susanna Esposito
Journal:  Paediatr Drugs       Date:  2016-02       Impact factor: 3.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.